StockClub
CTNMContineum Therapeutics, Inc.$ --
Contineum Therapeutics, Inc.

Contineum Therapeutics, Inc.

CTNM

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
0M USD
-

Operating Income

bar_chart
-68M USD
YoY -33.7%

Net Income

verified
-60M USD
YoY -41.9%

EPS

pie_chart
-2.17USD
YoY -33.1%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2026
Net Income Progress25.4%On Track
Revenue Progress0
Revenue Forecast10.3M
Net Income Progress-14.5M
Net Income Forecast-56.9M

Income Statement Details

Item
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
0
0
0
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
52
0
17
68
-68
Interest expense
Income before tax
Income tax expense
Net income
0
-60
0
-60

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.